Trial
NCT00096304
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Prostate Cancer
Intervention
docetaxel
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-10